Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka

Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka

Objectives To study if early initiation of inhaled beclomethasone 1200 mcg in patients with asymptomatic, mild or moderate COVID-19 reduces disease progression to severe COVID-19.Design Double-blinded, parallel-groups, randomised, placebo-controlled trial.Setting A hospital-based study in Sri Lanka....

Descripción completa

Detalles Bibliográficos
Autores principales: Chamila Mettananda, Arunasalam Pathmeswaran, Chathura Peiris, Dharani Abeyrathna, Aloka Gunasekara, Thimira Egodage, Channaka Dantanarayana, Channa Ranasinha
Formato: Artículo
Lenguaje:English
Publicado: BMJ Publishing Group 2023-12-01
Colección:BMJ Open
Acceso en línea:https://bmjopen.bmj.com/content/13/12/e075803.full

Internet

https://bmjopen.bmj.com/content/13/12/e075803.full

Ejemplares similares